123 related articles for article (PubMed ID: 12646962)
21. Real-time quantitation of minimal residual disease in inv(16)-positive acute myeloid leukemia may indicate risk for clinical relapse and may identify patients in a curable state.
Buonamici S; Ottaviani E; Testoni N; Montefusco V; Visani G; Bonifazi F; Amabile M; Terragna C; Ruggeri D; Piccaluga PP; Isidori A; Malagola M; Baccarani M; Tura S; Martinelli G
Blood; 2002 Jan; 99(2):443-9. PubMed ID: 11781223
[TBL] [Abstract][Full Text] [Related]
22. High concordance of karyotype analysis and RT-PCR for CBF beta/MYH11 in unselected patients with acute myeloid leukemia. A single center study.
Mitterbauer M; Laczika K; Novak M; Mitterbauer G; Hilgarth B; Pirc-Danoewinata H; Schwarzinger I; Haas OA; Fonatsch C; Lechner K; Jaeger U
Am J Clin Pathol; 2000 Mar; 113(3):406-10. PubMed ID: 10705822
[TBL] [Abstract][Full Text] [Related]
23. Identification of false-positive CBFbeta/MYH11 RT-PCR results.
Hackwell SM; Robinson DO; Harvey JF; Ross FM
Leukemia; 1999 Oct; 13(10):1617-9. PubMed ID: 10516764
[TBL] [Abstract][Full Text] [Related]
24. RAD51 and XRCC3 polymorphisms: impact on the risk and treatment outcomes of de novo inv(16) or t(16;16)/CBFβ-MYH11(+) acute myeloid leukemia.
Liu L; Yang L; Mi Y; Wang J; Li J; Zhang Y; Ma X; Qin T; Xu Z; Xiao Z
Leuk Res; 2011 Aug; 35(8):1020-6. PubMed ID: 21296419
[TBL] [Abstract][Full Text] [Related]
25. Myeloid sarcoma of the small bowel associated with a CBFbeta/MYH11 fusion and inv(16)(p13q22): a case report.
McKenna M; Arnold C; Catherwood MA; Humphreys MW; Cuthbert RJ; Bueso-Ramos C; McManus DT
J Clin Pathol; 2009 Aug; 62(8):757-9. PubMed ID: 19638550
[TBL] [Abstract][Full Text] [Related]
26. Competitive CBFbeta/MYH11 reverse-transcriptase polymerase chain reaction for quantitative assessment of minimal residual disease during postremission therapy in acute myeloid leukemia with inversion(16): a pilot study.
Laczika K; Novak M; Hilgarth B; Mitterbauer M; Mitterbauer G; Scheidel-Petrovic A; Scholten C; Thalhammer-Scherrer R; Brugger S; Keil F; Schwarzinger I; Haas OA; Lechner K; Jaeger U
J Clin Oncol; 1998 Apr; 16(4):1519-25. PubMed ID: 9552061
[TBL] [Abstract][Full Text] [Related]
27. [Detection of CBF beta-MYH11 fusion transcript and inv(16)(p13;q22) in acute myelomonocytic leukemia(M4) by RT-PCR and FISH].
He K; Gu B; Cao Q
Zhonghua Xue Ye Xue Za Zhi; 1998 Jan; 19(1):23-6. PubMed ID: 10921098
[TBL] [Abstract][Full Text] [Related]
28. Reported cryptic rearrangements of CBFbeta-MYH11 in acute myeloid leukaemia are not due to false priming of contaminating DNA.
Langabeer SE; Gale RE; Walker H; Linch DC
Leukemia; 2000 May; 14(5):944-5. PubMed ID: 10803531
[No Abstract] [Full Text] [Related]
29. [Detection of PEBP2 beta/MYH11 fusion mRNA in acute myelomonocytic leukemia without marrow eosinophilia].
Morinaga S; Osato M; Yanabe Y; Takaki K; Kawano F; Asou N; Takatsuki K; Tsuchiya H; Matsuda I
Rinsho Ketsueki; 1996 Jul; 37(7):618-23. PubMed ID: 8779782
[TBL] [Abstract][Full Text] [Related]
30. Acute myeloblastic leukemia (AML) with inv (16)(p13;q22) and the rare I type CBFbeta-MYH11 transcript: report of two new cases.
Grardel N; Roumier C; Soenen V; Lai JL; Plantier I; Gheveart C; Cosson A; Fenaux P; Preudhomme C
Leukemia; 2002 Jan; 16(1):150-1. PubMed ID: 11840275
[No Abstract] [Full Text] [Related]
31. Pathogenesis of acute myeloid leukaemia and inv(16)(p13;q22): a paradigm for understanding leukaemogenesis?
Reilly JT
Br J Haematol; 2005 Jan; 128(1):18-34. PubMed ID: 15606546
[TBL] [Abstract][Full Text] [Related]
32. Simple method for detection of MYH11 DNA rearrangements in patients with inv(16)(p13q22) and acute myeloid leukemia.
van der Reijden BA; Martinet D; Dauwerse JG; Giles RH; Wessels JW; Beverstock GC; Smit B; Mühlematter D; Jotterand Bellomo M; Gabert J; Lafage-Pochitaloff M; Reiffers J; Bilhou-Nabera C; van Ommen GJ; Hagemeijer A; Breuning MH
Leukemia; 1996 Sep; 10(9):1459-62. PubMed ID: 8751463
[TBL] [Abstract][Full Text] [Related]
33. WT1 gene expression: an excellent tool for monitoring minimal residual disease in 70% of acute myeloid leukaemia patients - results from a single-centre study.
Østergaard M; Olesen LH; Hasle H; Kjeldsen E; Hokland P
Br J Haematol; 2004 Jun; 125(5):590-600. PubMed ID: 15147374
[TBL] [Abstract][Full Text] [Related]
34. Minimal residual disease quantification in patients with acute myeloid leukaemia and inv(16)/CBFB-MYH11 gene fusion.
van der Reijden BA; Simons A; Luiten E; van der Poel SC; Hogenbirk PE; Tönnissen E; Valk PJ; Löwenberg B; De Greef GE; Breuning MH; Jansen JH
Br J Haematol; 2002 Aug; 118(2):411-8. PubMed ID: 12139724
[TBL] [Abstract][Full Text] [Related]
35. Detection and quantitation of the CBFbeta/MYH11 transcripts associated with the inv(16) in presentation and follow-up samples from patients with AML.
Evans PA; Short MA; Jack AS; Norfolk DR; Child JA; Shiach CR; Davies F; Tobal K; Liu Yin JA; Morgan GJ
Leukemia; 1997 Mar; 11(3):364-9. PubMed ID: 9067575
[TBL] [Abstract][Full Text] [Related]
36. Molecular analysis of a new variant of the CBF beta-MYH11 gene fusion.
Stulberg J; Kamel-Reid S; Chun K; Tokunaga J; Wells RA
Leuk Lymphoma; 2002 Oct; 43(10):2021-6. PubMed ID: 12481902
[TBL] [Abstract][Full Text] [Related]
37. [Relationship between RAD51-g135C and XRCC3-C241T polymorphisms and prognosis of inv (16)/ t(16;16) (CBFbeta-MYH11) acute myeloid leukemia].
Liu L; Yang L; Mi YC; Li JY; Qin TJ; Xu ZF; Zhang Y; Wang JX; Xiao ZJ
Zhonghua Xue Ye Xue Za Zhi; 2011 Jul; 32(7):433-8. PubMed ID: 22213860
[TBL] [Abstract][Full Text] [Related]
38. A case of therapy-related acute myeloid leukemia associated with inv(16), with subsequent development of t(9;22).
Kim M; Lim J; Kim Y; Han K; Kang CS; Kim HJ; Min WS
Leukemia; 2006 Apr; 20(4):746-8. PubMed ID: 16437154
[No Abstract] [Full Text] [Related]
39. Type J CBFbeta/MYH11 transcript in the M4Eo subtype of acute myeloid leukemia.
Trnková Z; Peková S; Bedrlíková R; Záková D; Zemanová Z; Polák J; Michalová K; Cermák J; Schwarz J
Hematology; 2003 Apr; 8(2):115-7. PubMed ID: 12745661
[TBL] [Abstract][Full Text] [Related]
40. Defining the "absence" of the CBFbeta/MYH11 fusion transcript in patients with acute myeloid leukemia and inversion of chromosome 16 to predict long-term complete remission: a call for definitions.
Marcucci G; Caligiuri MA; Bloomfield CD
Blood; 1997 Dec; 90(12):5022-5024. PubMed ID: 9389723
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
